PDS Planning Inc Acquires 51 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

PDS Planning Inc lifted its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 3.8% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,385 shares of the medical equipment provider’s stock after purchasing an additional 51 shares during the quarter. PDS Planning Inc’s holdings in Intuitive Surgical were worth $723,000 as of its most recent SEC filing.

Other institutional investors have also made changes to their positions in the company. M.E. Allison & CO. Inc. bought a new stake in shares of Intuitive Surgical in the fourth quarter worth $449,000. Seilern Investment Management Ltd bought a new stake in shares of Intuitive Surgical in the fourth quarter worth $82,517,000. Sycomore Asset Management lifted its position in shares of Intuitive Surgical by 27.4% in the fourth quarter. Sycomore Asset Management now owns 18,945 shares of the medical equipment provider’s stock worth $9,214,000 after purchasing an additional 4,079 shares in the last quarter. Exome Asset Management LLC increased its holdings in Intuitive Surgical by 16.8% during the third quarter. Exome Asset Management LLC now owns 7,427 shares of the medical equipment provider’s stock worth $3,649,000 after buying an additional 1,069 shares during the last quarter. Finally, China Universal Asset Management Co. Ltd. increased its holdings in Intuitive Surgical by 5.6% during the fourth quarter. China Universal Asset Management Co. Ltd. now owns 9,843 shares of the medical equipment provider’s stock worth $5,138,000 after buying an additional 525 shares during the last quarter. Institutional investors own 83.64% of the company’s stock.

Insider Activity

In related news, EVP Robert Desantis sold 11,545 shares of the company’s stock in a transaction dated Thursday, March 13th. The shares were sold at an average price of $499.22, for a total transaction of $5,763,494.90. Following the completion of the sale, the executive vice president now owns 5,224 shares of the company’s stock, valued at $2,607,925.28. This represents a 68.85 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Director Amal M. Johnson sold 4,635 shares of the company’s stock in a transaction dated Tuesday, January 28th. The stock was sold at an average price of $566.60, for a total transaction of $2,626,191.00. Following the sale, the director now directly owns 12,275 shares of the company’s stock, valued at $6,955,015. This represents a 27.41 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 33,754 shares of company stock valued at $17,691,621. 0.90% of the stock is owned by company insiders.

Intuitive Surgical Stock Performance

Shares of Intuitive Surgical stock opened at $488.80 on Tuesday. The firm has a 50-day moving average of $566.38 and a 200-day moving average of $531.96. The stock has a market cap of $174.10 billion, a PE ratio of 76.26, a PEG ratio of 5.85 and a beta of 1.43. Intuitive Surgical, Inc. has a 52-week low of $364.17 and a 52-week high of $616.00.

Analyst Ratings Changes

A number of equities analysts recently weighed in on ISRG shares. Royal Bank of Canada boosted their target price on shares of Intuitive Surgical from $611.00 to $641.00 in a report on Monday, January 27th. JPMorgan Chase & Co. boosted their target price on shares of Intuitive Surgical from $575.00 to $675.00 and gave the stock an “overweight” rating in a report on Friday, January 24th. Wells Fargo & Company boosted their target price on shares of Intuitive Surgical from $630.00 to $687.00 and gave the stock an “overweight” rating in a report on Friday, January 24th. Raymond James boosted their target price on shares of Intuitive Surgical from $560.00 to $688.00 and gave the stock an “outperform” rating in a report on Friday, January 24th. Finally, Barclays boosted their target price on shares of Intuitive Surgical from $610.00 to $674.00 in a report on Monday, January 27th. One analyst has rated the stock with a sell rating, four have issued a hold rating and sixteen have assigned a buy rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $610.19.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.